Search results
10 Adult ADHD Signs You May Not Realize Are Actually Symptoms
The Huffington Post· 2 days agoThe hallmark symptoms of ADHD — inattention, impulsivity and hyperactivity — typically aren’t as...
Progress Toward a New GAD Treatment Paradigm
FierceBiotech· 7 hours agoHealth Awareness Month, and an appropriate time to shine a spotlight on a mental health disorder that has been underserved and underacknowledged for too...
Perimenopause may raise risk of one mental health condition by 40%, study finds
CNN.com· 6 days agoIn the years leading up to menopause, a person can experience a multitude of symptoms, including...
Depression: Psilocybin from magic mushrooms shows promise as treatment
Medical News Today· 3 days agoResearchers also reported that psilocybin showed greater effects on people with secondary depression...
Psilocybin outperforms other treatments in easing depression in study
United Press International via Yahoo News· 4 days agoThose control groups received either placebo medications, the dietary supplement niacin (vitamin B),...
Depression: Researchers say risk higher for women during perimenopause
Medical News Today· 5 days agoThe researchers concluded that the risk of depression in perimenopause highlights the need for...
Magic Mushrooms Show Potency Against Depression
SciTechDaily· 3 days agoFindings are encouraging but further evidence is needed before any clinical recommendations can be made, say experts. Psilocybin — the active ingredient...
Cybin advances in depression, anxiety treatments By Investing.com
Investing.com· 6 hours agoCybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN), a clinical-stage biopharmaceutical company, has...
NRx Pharmaceuticals climbs on positive results from its bipolar depression treatment trial
Seeking Alpha· 6 hours agoNRx Pharmaceuticals announces statistically significant safety advantage of NRX-101 in suicidal bipolar depression trial.
...) Announces Promising Findings in Phase 2b/3 Clinical Trial of NRX-101 vs. Lurasidone for...
KSAN - KLST San Angelo· 6 days agoNRX-101 is first oral antidepressant to show 33% advantage in sustained remission in suicidality (not statistically significant at this sample size) and 75% advantage in relief from Akathisia ...
